Innovation Overground: CAR-T cell therapy powers the immune system to fight cancer

March 11, 2019 News

OMAHA, Neb. (March 11, 2019)—UNeMed’s tech transfer podcast, “Innovation Overground,” published this morning its latest episode, “Medicine gets personal with CAR-T and good touches.”

In the latest episode, Overground hosts Joe Runge, Tyler Scherr and Charlie Litton, discuss CART-T therapy—an approach to cancer treatment that involves training the human immune system to go after tumors.

Innovation Overground was created to help promote academic innovation and the technology transfer and commercialization efforts at the University of Nebraska and beyond. The podcast intends to examine what it takes to advance academic inventions and discoveries beyond the research bench and into people’s lives as “actual things on a shelf.”

New episodes are published on Mondays, and are available on most podcast channels, including Google Play Music, iTunes, iHeartMusic, Podomatic, Spotify and Spreaker.

Use the below links to subscribe, listen to previous episodes and learn more.

Listen on Apple Podcasts
Listen on Google Play Music
Listen on iHeart Radio
Innovation Overground on Spotify
Listen to this podcast on Spreaker
Player FM
Pocket Cast
Luminary
 

,

News Innovation Overground: CAR-T cell therapy powers the immune system to fight cancer

Charles Litton is the communications associate at UNeMed Corporation, the technology transfer and commercialization office (TTO) for the University of Nebraska Medical Center. UNeMed serves all UNMC researchers, faculty and staff who develop new biomedical technology and inventions, and strives to help bring those innovations to the marketplace. Contact the author at charles.litton@unmc.edu or 402-559-2468.

Related Posts

Comments are closed.